Trial Profile
A Randomized, Double-Blind, Multiple-Ascending-Dose, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO4998452 Following Oral Administrations in Patients With Type 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Tofogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Roche
- 18 Nov 2009 Status changed from active, no longer recruiting to completed as reported by Roche website.
- 18 Nov 2009 Status changed from active, no longer recruiting to completed as reported by Roche website.
- 18 Nov 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.